Outset Medical Director Braden Leonard Purchases $870K in Shares

Outset Medical director Braden Michael Leonard increased his stake in the company by purchasing $870,260 in shares through open-market transactions on October 1 and October 2, 2026. This action indicates insider confidence in the medical technology company, which has experienced recent share price fluctuations.

According to an SEC Form 4 filing, Leonard acquired 228,334 shares on October 1 and 16,575 shares on October 2. The purchase prices for these transactions ranged from approximately $3.53 to $3.8758 per share.

Transaction Structure and Ownership

The shares are held indirectly through BML Investment Partners, L.P. Leonard serves as the managing member of the general partner, BML Capital Management, LLC, which manages the investment vehicle. Following these acquisitions, Leonard's total indirect beneficial ownership in Outset Medical, Inc. has reached 2,764,610 shares.

Market Context for Outset Medical

These insider purchases occur as Outset Medical navigates a period of market volatility. As of the close of trading on October 9, 2026, Outset Medical (OM) stock was priced at $4.05, a 0.98% decline from the previous session.

For context, the company has focused on managing its capital structure and operational efficiency, as detailed in recent SEC filings. Market participants track insider buying to gauge management's internal outlook on the company's valuation, particularly when shares have experienced a sustained decline.